  To evaluate the PAQ Adults with Type 2 diabetes with HbA A total of 28 adults were enrolled ( age 63 ± 7 years , 86 % men , BMI 32.3 ± 4.3 kg/m Adults with Type 2 diabetes were safely transitioned from insulin injections to the PAQ and had significantly improved glycaemic control and treatment satisfaction with insulin therapy. ( ClinicalTrials.gov identifiers: NCT02158078 & NCT02419859).